Recruiting
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
NCT05997615
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +11 more
- Locations
-
- Investigational Site Number: 403 Palo Alto, California, United States
- Investigational Site Number: 401 Houston, Texas, United States
- Investigational Site number: 404 Fairfax, Virginia, United States
- Investigational Site Number: 400 Seattle, Washington, United States